zPredicta partners with LabCorp for cell cultures R&D

By The Science Advisory Board staff writers

February 28, 2020 -- LabCorp and zPredicta have partnered to promote the use of 3D cell cultures for drug research and development.

The collaboration fuses zPredicta's cell culture models with LabCorp's precision medicine platform. zPredicta anticipates the partnership will bolster the adoption of its 3D cell culture system.

LabCorp adopts Thermo Fisher NGS for companion diagnostics
LabCorp announced on January 14 that it will adopt Thermo Fisher Scientific's Ion Torrent Genexus next-generation sequencing (NGS) system and Oncomine...
Direct-to-consumer Testing Kits Exploded in 2018
Consumers are directing healthcare in many ways, but ordering clinical testing was, until recently, the exclusive purview of physicians. That’s changing...

Copyright © 2020 scienceboard.net


Conferences
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter